tazobactam has been researched along with ambroxol in 2 studies
Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (ambroxol) | Trials (ambroxol) | Recent Studies (post-2010) (ambroxol) |
---|---|---|---|---|---|
1,327 | 153 | 694 | 714 | 130 | 225 |
Protein | Taxonomy | tazobactam (IC50) | ambroxol (IC50) |
---|---|---|---|
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 4.1 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.5574 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.391 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Dong, M; Gong, C; Huang, F; Jiao, Y; Li, AH; Li, MZ; Luo, M; Zhang, TG | 1 |
2 other study(ies) available for tazobactam and ambroxol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A Pneumonia Case Associated with Type 2 Polio Vaccine Strains.
Topics: Ambroxol; Anti-Bacterial Agents; Humans; Infant; Male; Penicillanic Acid; Pneumonia; Poliomyelitis; Tazobactam; Vaccines | 2017 |